Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report)’s stock price rose 0.3% during trading on Monday. The stock traded as high as $1.9860 and last traded at $1.9860. Approximately 2,000 shares traded hands during mid-day trading, The stock had previously closed at $1.98.
Polydex Pharmaceuticals Stock Performance
The stock has a 50-day moving average of $1.99 and a 200 day moving average of $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Limited is a Canadian specialty pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. Its activities have included products for human and veterinary use, with an emphasis on specialized and injectable medicines.
The company also operates in related pharmaceutical and chemical product areas, serving customers through commercial and distribution channels in Canada and selected international markets. Its business includes the production and sale of both prescription and nonprescription products, although the availability of specific products and markets may change over time.
Polydex Pharmaceuticals has historically focused on niche healthcare products rather than operating as a diversified, large-scale drug manufacturer.
Further Reading
- Five stocks we like better than Polydex Pharmaceuticals
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
